Show simple item record

Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness

dc.contributor.authorThompson-Coon, Jo
dc.contributor.authorLiu, Z
dc.contributor.authorHoyle, M
dc.contributor.authorRogers, G
dc.contributor.authorGreen, C
dc.contributor.authorMoxham, T
dc.contributor.authorWelch, K
dc.contributor.authorStein, Ken
dc.date.accessioned2015-05-12T12:03:12Z
dc.date.issued2009-07-21
dc.description.abstractTwo new agents have recently been licensed for use in the treatment of metastatic renal cell carcinoma (RCC) in Europe. This paper aims to systematically review the evidence from all available randomised clinical trials of sunitinib and bevacizumab (in combination with interferon-alpha (IFN-alpha)) in the treatment of advanced metastatic RCC.en_GB
dc.identifier.citationVol. 101, Issue 2, pp. 238 - 243en_GB
dc.identifier.doi10.1038/sj.bjc.6605167
dc.identifier.other6605167
dc.identifier.urihttp://hdl.handle.net/10871/17202
dc.language.isoenen_GB
dc.publisherCancer Research UKen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/19568242en_GB
dc.relation.urlhttp://www.nature.com/bjc/journal/v101/n2/full/6605167a.htmlen_GB
dc.rightsThis is an open access article. This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/en_GB
dc.subjectAntibodies, Monoclonalen_GB
dc.subjectAntibodies, Monoclonal, Humanizeden_GB
dc.subjectAntineoplastic Combined Chemotherapy Protocolsen_GB
dc.subjectCarcinoma, Renal Cellen_GB
dc.subjectClinical Trials, Phase III as Topicen_GB
dc.subjectDisease-Free Survivalen_GB
dc.subjectHumansen_GB
dc.subjectIndolesen_GB
dc.subjectInterferon-alphaen_GB
dc.subjectKidney Neoplasmsen_GB
dc.subjectPyrrolesen_GB
dc.subjectRandomized Controlled Trials as Topicen_GB
dc.titleSunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectivenessen_GB
dc.typeArticleen_GB
dc.date.available2015-05-12T12:03:12Z
dc.identifier.issn0007-0920
exeter.place-of-publicationEngland
dc.descriptionnotes: PMCID: PMC2720220en_GB
dc.descriptiontypes: Comparative Study; Journal Article; Reviewen_GB
dc.descriptionCopyright © 2009 Cancer Research UKen_GB
dc.identifier.journalBritish Journal of Canceren_GB


Files in this item

Name:
Br J Cancer 2009 - Thompson-Co ...
Size:
88.61Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record